Marksans Pharma Limited (BOM:524404)
India · Delayed Price · Currency is INR 266.85
-0.25 (-0.09%)
At close: Jul 20, 2026
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 120.97 billion as of July 21, 2026. Its market cap has increased by 4.38% in one year.
Market Cap
120.97B
Enterprise Value
114.80B
Revenue
29.51B
Ranking
n/a
PE Ratio
28.95
Stock Price
266.85
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 120.97B, an increase of 3,212.89%. That is a compound annual growth rate of 19.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 120.97B | 48.07% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 237.17B |
| Granules India | 218.09B |
| AstraZeneca Pharma India | 200.65B |
| Caplin Point Laboratories | 198.69B |
| Jubilant Pharmova | 161.92B |
| CORONA Remedies | 126.12B |
| Viyash Scientific | 117.45B |
| Procter & Gamble Health | 112.84B |